» Articles » PMID: 31706984

A Highly Productive, One-Pot Cell-Free Protein Synthesis Platform Based on Genomically Recoded Escherichia Coli

Overview
Journal Cell Chem Biol
Publisher Cell Press
Specialty Biochemistry
Date 2019 Nov 11
PMID 31706984
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The site-specific incorporation of non-canonical amino acids (ncAAs) into proteins via amber suppression provides access to novel protein properties, structures, and functions. Historically, poor protein expression yields resulting from release factor 1 (RF1) competition has limited this technology. To address this limitation, we develop a high-yield, one-pot cell-free platform for synthesizing proteins bearing ncAAs based on genomically recoded Escherichia coli lacking RF1. A key feature of this platform is the independence on the addition of purified T7 DNA-directed RNA polymerase (T7RNAP) to catalyze transcription. Extracts derived from our final strain demonstrate high productivity, synthesizing 2.67 ± 0.06 g/L superfolder GFP in batch mode without supplementation of purified T7RNAP. Using an optimized one-pot platform, we demonstrate multi-site incorporation of the ncAA p-acetyl-L-phenylalanine into an elastin-like polypeptide with high accuracy of incorporation and yield. Our work has implications for chemical and synthetic biology.

Citing Articles

Cell-free expression system: a promising platform for bacteriophage production and engineering.

Nour El-Din H, Kettal M, Lam S, Granados Maciel J, Peters D, Chen W Microb Cell Fact. 2025; 24(1):42.

PMID: 39962567 PMC: 11834285. DOI: 10.1186/s12934-025-02661-9.


Beyond , Pharmaceutical Molecule Production in Cell-Free Systems and the Use of Noncanonical Amino Acids Therein.

Casteleijn M, Abendroth U, Zemella A, Walter R, Rashmi R, Haag R Chem Rev. 2025; 125(3):1303-1331.

PMID: 39841856 PMC: 11826901. DOI: 10.1021/acs.chemrev.4c00126.


Protein Expression Platforms and the Challenges of Viral Antigen Production.

Sookhoo J, Schiffman Z, Ambagala A, Kobasa D, Pardee K, Babiuk S Vaccines (Basel). 2025; 12(12.

PMID: 39772006 PMC: 11680109. DOI: 10.3390/vaccines12121344.


Cell-Free Gene Expression: Methods and Applications.

Hunt A, Rasor B, Seki K, Ekas H, Warfel K, Karim A Chem Rev. 2024; 125(1):91-149.

PMID: 39700225 PMC: 11719329. DOI: 10.1021/acs.chemrev.4c00116.


Screening antimicrobial peptides and probiotics using multiple deep learning and directed evolution strategies.

Zhang Y, Liu L, Xu B, Zhang Z, Yang M, He Y Acta Pharm Sin B. 2024; 14(8):3476-3492.

PMID: 39234615 PMC: 11372459. DOI: 10.1016/j.apsb.2024.05.003.


References
1.
Schoborg J, Hershewe J, Stark J, Kightlinger W, Kath J, Jaroentomeechai T . A cell-free platform for rapid synthesis and testing of active oligosaccharyltransferases. Biotechnol Bioeng. 2017; 115(3):739-750. DOI: 10.1002/bit.26502. View

2.
Mukai T, Hoshi H, Ohtake K, Takahashi M, Yamaguchi A, Hayashi A . Highly reproductive Escherichia coli cells with no specific assignment to the UAG codon. Sci Rep. 2015; 5:9699. PMC: 4434889. DOI: 10.1038/srep09699. View

3.
Oza J, Aerni H, Pirman N, Barber K, Ter Haar C, Rogulina S . Robust production of recombinant phosphoproteins using cell-free protein synthesis. Nat Commun. 2015; 6:8168. PMC: 4566161. DOI: 10.1038/ncomms9168. View

4.
Studier F, Moffatt B . Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol. 1986; 189(1):113-30. DOI: 10.1016/0022-2836(86)90385-2. View

5.
Martin R, Des Soye B, Kwon Y, Kay J, Davis R, Thomas P . Cell-free protein synthesis from genomically recoded bacteria enables multisite incorporation of noncanonical amino acids. Nat Commun. 2018; 9(1):1203. PMC: 5865108. DOI: 10.1038/s41467-018-03469-5. View